STSA

Satsuma Pharmaceuticals Stock Price

6.30
0.80 (14.55%)
Upgrade to Real-Time
Afterhours (Closed)
6.30
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Satsuma Pharmaceuticals Inc STSA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.80 14.55% 6.30 19:58:24
Open Price Low Price High Price Close Price Prev Close
5.49 5.425 7.00 6.21 5.50
Bid Price Ask Price Spread News
6.25 6.30 0.05 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,237 3,058,514 $ 6.23 $ 19,066,231 385,776 3.50 - 36.105
Last Trade Time Type Quantity Stock Price Currency
19:58:24 formt 141 $ 6.30 USD

Satsuma Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 109.76M 17.42M 6.63M $ - $ - 1.11 2.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.90%

more financials information »

Satsuma Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STSA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.047.004.96185.44303,6471.2625.0%
1 Month5.117.004.385.01333,7871.1923.29%
3 Months3.587.003.504.65352,2082.7275.98%
6 Months26.2826.793.505.511,391,485-19.98-76.03%
1 Year19.9936.1053.506.32716,894-13.69-68.48%
3 Years19.0036.1053.506.69552,527-12.70-66.84%
5 Years19.0036.1053.506.69552,527-12.70-66.84%

Satsuma Pharmaceuticals Description

Satsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.


Your Recent History
NASDAQ
STSA
Satsuma Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.